Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ascentage Pharma Group Inc.

Clinical trials sponsored by Ascentage Pharma Group Inc., explained in plain language.

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 2

New hope for lung cancer patients when standard drugs fail

Disease control Ongoing

This study is testing the safety and effectiveness of combining an experimental drug called APG-1252 with an existing lung cancer drug, osimertinib. It is for people with advanced EGFR-positive non-small cell lung cancer whose disease has progressed after previous treatments. The…

Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC